Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.11 trillion and total revenue of $110.04 billion.
Market Cap
1.11T
Revenue
110.04B
Profits
-40.71B
PE Ratio
n/a
Profit Margin
-37.00%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 117.08B | 0.92% | 1,179,692 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.21B | 2.86% | 696,861 | 14.34B |
| 3 | ARGX | argenx SE | 44.74B | 3.15% | 441,217 | 4.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.92B | 0.91% | 1,080,916 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.54B | 0.39% | 198,113 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.85B | 2.14% | 1,801,896 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 26.44B | 0.95% | 3,899,489 | 2.38B |
| 8 | BNTX | BioNTech SE | 25.64B | 0.65% | 1,031,904 | 3.70B |
| 9 | MRNA | Moderna, Inc. | 22.01B | 6.13% | 13,831,034 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.13B | 2.61% | 8,810,853 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.78B | 1.41% | 1,497,706 | - |
| 12 | INCY | Incyte Corporation | 19.32B | 1.21% | 1,520,881 | 5.14B |
| 13 | GMAB | Genmab A/S | 16.46B | 0.67% | 1,348,074 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 14.73B | -0.30% | 747,987 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 12.73B | 0.43% | 1,780,196 | 502.08M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 12.45B | 1.78% | 3,239,896 | 943.71M |
| 17 | SMMT | Summit Therapeutics Inc. | 12.19B | 4.04% | 2,720,032 | - |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 11.71B | -0.39% | 1,300,718 | 3.22B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 11.41B | 1.86% | 715,338 | 4.27B |
| 20 | EXEL | Exelixis, Inc. | 11.00B | 1.97% | 3,166,860 | 2.32B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.94B | 0.09% | 288,833 | 958.40M |
| 22 | IBRX | ImmunityBio, Inc. | 8.69B | -2.54% | 25,645,348 | 113.29M |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 8.61B | -0.55% | 478,877 | 7.46M |
| 24 | TECH | Bio-Techne Corporation | 8.58B | 1.82% | 2,676,959 | 1.22B |
| 25 | ABVX | ABIVAX Société Anonyme | 8.56B | 0.26% | 648,783 | 6.23M |
| 26 | PCVX | Vaxcyte, Inc. | 8.54B | 0.05% | 1,035,063 | - |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.50B | 1.42% | 2,260,248 | 1.09B |
| 28 | AXSM | Axsome Therapeutics, Inc. | 8.41B | 1.33% | 425,545 | 638.50M |
| 29 | NUVL | Nuvalent, Inc. | 8.04B | 2.93% | 484,429 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.04B | 1.14% | 1,610,454 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 7.69B | 3.33% | 2,557,793 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.56B | 1.96% | 259,776 | 389.13M |
| 33 | BLTE | Belite Bio, Inc | 7.05B | 3.36% | 116,491 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.94B | 1.86% | 438,083 | 39.21M |
| 35 | ACLX | Arcellx, Inc. | 6.70B | 0.15% | 1,420,157 | 22.29M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.35B | -0.56% | 620,181 | 189.76M |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.17B | 4.96% | 726,691 | 46.02M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.96B | -0.19% | 1,989,829 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.66B | 8.88% | 2,494,615 | 1.73B |
| 40 | CRSP | CRISPR Therapeutics AG | 5.64B | 4.04% | 1,260,768 | 3.51M |
| 41 | IMVT | Immunovant, Inc. | 5.38B | -0.94% | 1,234,582 | - |
| 42 | CAI | Caris Life Sciences, Inc. | 5.37B | 2.21% | 2,688,388 | 812.03M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 5.36B | 2.87% | 1,099,281 | 521.31M |
| 44 | CELC | Celcuity Inc. | 5.25B | -1.35% | 963,037 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 5.22B | 49.64% | 11,514,947 | 7.50M |
| 46 | CGON | CG Oncology, Inc. | 5.18B | -0.95% | 1,241,803 | 4.04M |
| 47 | APGE | Apogee Therapeutics, Inc. | 5.16B | 2.59% | 856,688 | - |
| 48 | SRRK | Scholar Rock Holding Corporation | 5.08B | -2.34% | 1,055,254 | - |
| 49 | ERAS | Erasca, Inc. | 4.88B | 1.87% | 4,157,356 | - |
| 50 | TERN | Terns Pharmaceuticals, Inc. | 4.82B | 3.43% | 1,544,671 | - |
| 51 | FOLD | Amicus Therapeutics, Inc. | 4.51B | 0.21% | 2,577,907 | 634.21M |
| 52 | TGTX | TG Therapeutics, Inc. | 4.31B | -0.27% | 1,654,506 | 616.29M |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.15B | 3.10% | 166,995 | 268.09M |
| 54 | GPCR | Structure Therapeutics Inc. | 4.00B | -2.13% | 882,807 | - |
| 55 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.00B | -0.03% | 1,258,650 | 7.70M |
| 56 | VKTX | Viking Therapeutics, Inc. | 3.88B | 1.91% | 1,932,290 | - |
| 57 | ACAD | ACADIA Pharmaceuticals Inc. | 3.85B | 1.90% | 1,753,050 | 1.07B |
| 58 | CNTA | Centessa Pharmaceuticals plc | 3.81B | 0.54% | 1,009,956 | 15.00M |
| 59 | ADMA | ADMA Biologics, Inc. | 3.77B | 2.73% | 3,056,149 | 510.17M |
| 60 | CORT | Corcept Therapeutics Incorporated | 3.62B | 0.35% | 1,203,169 | 761.41M |
| 61 | NAMS | NewAmsterdam Pharma Company N.V. | 3.54B | 3.05% | 761,265 | 22.50M |
| 62 | LEGN | Legend Biotech Corporation | 3.53B | 0.90% | 1,380,228 | 909.05M |
| 63 | DNTH | Dianthus Therapeutics, Inc. | 3.52B | 21.52% | 4,611,127 | 2.04M |
| 64 | DNLI | Denali Therapeutics Inc. | 3.38B | 8.23% | 2,627,001 | - |
| 65 | ALMS | Alumis Inc. | 3.35B | -0.22% | 1,811,911 | 22.12M |
| 66 | SYRE | Spyre Therapeutics, Inc. | 3.23B | 2.29% | 890,308 | - |
| 67 | TARS | Tarsus Pharmaceuticals, Inc. | 3.17B | 1.68% | 476,041 | 451.36M |
| 68 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | 5.69% | 934,723 | 218.71M |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 3.08B | 3.42% | 1,035,854 | 376.07M |
| 70 | EWTX | Edgewise Therapeutics, Inc. | 3.07B | 3.02% | 1,143,018 | - |
| 71 | VRDN | Viridian Therapeutics, Inc. | 3.03B | 4.62% | 1,270,604 | 70.85M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.03B | 2.27% | 914,566 | 588.99M |
| 73 | RCUS | Arcus Biosciences, Inc. | 2.94B | 5.97% | 1,421,133 | 247.00M |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.92B | 19.04% | 5,279,679 | - |
| 75 | VERA | Vera Therapeutics, Inc. | 2.78B | -0.26% | 1,278,313 | - |
| 76 | BEAM | Beam Therapeutics Inc. | 2.74B | 4.07% | 1,243,238 | 139.74M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.67B | 6.39% | 1,273,166 | 490.73M |
| 78 | APLS | Apellis Pharmaceuticals, Inc. | 2.56B | -0.40% | 1,660,987 | 1.00B |
| 79 | WVE | Wave Life Sciences Ltd. | 2.50B | 1.30% | 2,792,742 | 42.73M |
| 80 | IRON | Disc Medicine, Inc. | 2.45B | 4.99% | 954,527 | - |
| 81 | TLX | Telix Pharmaceuticals Limited | 2.44B | -0.40% | 162,331 | 803.79M |
| 82 | IMNM | Immunome, Inc. | 2.41B | 1.38% | 975,776 | 6.94M |
| 83 | TNGX | Tango Therapeutics, Inc. | 2.35B | -2.95% | 3,535,265 | 62.38M |
| 84 | ADPT | Adaptive Biotechnologies Corporation | 2.30B | 0.61% | 3,493,672 | 276.98M |
| 85 | IOVA | Iovance Biotherapeutics, Inc. | 2.23B | 5.46% | 27,550,672 | 263.50M |
| 86 | DAWN | Day One Biopharmaceuticals, Inc. | 2.20B | 0.61% | 12,246,767 | 158.18M |
| 87 | STOK | Stoke Therapeutics, Inc. | 2.19B | 7.98% | 750,326 | 205.63M |
| 88 | RARE | Ultragenyx Pharmaceutical Inc. | 2.18B | 6.40% | 2,256,997 | 673.00M |
| 89 | MAZE | Maze Therapeutics, Inc. | 2.17B | 0.51% | 495,465 | 2.50M |
| 90 | OCUL | Ocular Therapeutix, Inc. | 2.16B | -3.21% | 5,819,123 | 51.95M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.16B | 2.44% | 864,203 | - |
| 92 | GLPG | Galapagos NV | 2.15B | 0.43% | 83,895 | 1.31B |
| 93 | ZLAB | Zai Lab Limited | 2.14B | -2.15% | 536,911 | 460.16M |
| 94 | SNDX | Syndax Pharmaceuticals, Inc. | 2.11B | 8.20% | 2,554,103 | 172.35M |
| 95 | SLNO | Soleno Therapeutics, Inc. | 2.05B | 0.23% | 1,277,171 | 190.41M |
| 96 | AAPG | Ascentage Pharma Group International | 2.05B | 2.38% | 1,359 | 54.52M |
| 97 | CLDX | Celldex Therapeutics, Inc. | 2.05B | 4.42% | 1,677,758 | 1.55M |
| 98 | NKTR | Nektar Therapeutics | 1.93B | -2.19% | 1,435,437 | 62.60M |
| 99 | MESO | Mesoblast Limited | 1.92B | -2.65% | 214,931 | 65.38M |
| 100 | MANE | Veradermics, Incorporated | 1.92B | 5.68% | 466,380 | - |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.91B | 0.35% | 1,361,549 | 283.06M |
| 102 | NBTX | Nanobiotix S.A. | 1.88B | 18.06% | 101,804 | 11.93M |
| 103 | RXRX | Recursion Pharmaceuticals, Inc. | 1.85B | 1.45% | 12,798,504 | 74.68M |
| 104 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | 5.57% | 3,725,383 | 2.20B |
| 105 | PVLA | Palvella Therapeutics, Inc. | 1.84B | 1.72% | 258,600 | - |
| 106 | DFTX | Definium Therapeutics, Inc. | 1.83B | 3.91% | 1,626,363 | - |
| 107 | TYRA | Tyra Biosciences, Inc. | 1.82B | -3.68% | 1,279,876 | - |
| 108 | RLAY | Relay Therapeutics, Inc. | 1.81B | 2.53% | 2,455,536 | 15.36M |
| 109 | ZYME | Zymeworks Inc. | 1.79B | 0.71% | 963,796 | 105.97M |
| 110 | ELVN | Enliven Therapeutics, Inc. | 1.78B | 0.99% | 574,931 | - |
| 111 | VCEL | Vericel Corporation | 1.73B | 1.22% | 558,330 | 276.26M |
| 112 | GLTO | Galecto, Inc. | 1.73B | -0.76% | 231,691 | - |
| 113 | PHVS | Pharvaris N.V. | 1.72B | 2.32% | 183,853 | - |
| 114 | NVAX | Novavax, Inc. | 1.72B | 5.71% | 5,567,064 | 1.12B |
| 115 | ANAB | AnaptysBio, Inc. | 1.72B | 7.74% | 406,499 | 234.60M |
| 116 | IMCR | Immunocore Holdings plc | 1.69B | 1.43% | 220,716 | 400.02M |
| 117 | SION | Sionna Therapeutics, Inc. | 1.69B | 4.45% | 318,204 | - |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | 3.86% | 779,690 | 54.03M |
| 119 | INVA | Innoviva, Inc. | 1.65B | 1.32% | 591,897 | 411.33M |
| 120 | HRMY | Harmony Biosciences Holdings, Inc. | 1.65B | 0.85% | 696,267 | 868.45M |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.64B | 3.35% | 4,024,829 | 67.67M |
| 122 | ORKA | Oruka Therapeutics, Inc. | 1.63B | 2.06% | 397,452 | - |
| 123 | NUVB | Nuvation Bio Inc. | 1.62B | 3.05% | 6,664,722 | 62.90M |
| 124 | OCS | Oculis Holding AG | 1.62B | 1.52% | 288,028 | 1.51M |
| 125 | NRIX | Nurix Therapeutics, Inc. | 1.59B | 2.65% | 715,808 | 83.98M |
| 126 | KOD | Kodiak Sciences Inc. | 1.59B | 3.46% | 553,785 | - |
| 127 | CAPR | Capricor Therapeutics, Inc. | 1.58B | 9.78% | 2,668,993 | 11.13M |
| 128 | VIR | Vir Biotechnology, Inc. | 1.57B | 2.62% | 3,308,296 | 68.56M |
| 129 | GENB | Generate Biomedicines, Inc. | 1.55B | 8.56% | 810,736 | 31.89M |
| 130 | BHVN | Biohaven Ltd. | 1.54B | 2.92% | 5,987,827 | - |
| 131 | ARDX | Ardelyx, Inc. | 1.51B | -0.32% | 3,286,742 | 407.32M |
| 132 | TRVI | Trevi Therapeutics, Inc. | 1.50B | -12.03% | 1,862,995 | - |
| 133 | RAPP | Rapport Therapeutics, Inc. | 1.46B | 0.99% | 887,970 | - |
| 134 | ATAI | AtaiBeckley Inc. | 1.41B | 14.75% | 9,159,467 | 3.02M |
| 135 | ZBIO | Zenas BioPharma, Inc. | 1.40B | 3.32% | 532,227 | 15.00M |
| 136 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -0.79% | 686,098 | 181.54M |
| 137 | SVRA | Savara Inc. | 1.34B | 3.04% | 1,261,291 | - |
| 138 | IMTX | Immatics N.V. | 1.34B | 1.42% | 493,726 | 56.67M |
| 139 | CRVS | Corvus Pharmaceuticals, Inc. | 1.33B | 0.57% | 1,280,672 | - |
| 140 | MBX | MBX Biosciences, Inc. | 1.32B | -8.54% | 823,971 | - |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.31B | 0.94% | 924,709 | - |
| 142 | EYPT | EyePoint, Inc. | 1.31B | -0.51% | 1,486,705 | 31.37M |
| 143 | DBVT | DBV Technologies S.A. | 1.30B | 4.71% | 212,253 | 5.50M |
| 144 | SEPN | Septerna, Inc. | 1.30B | 0.97% | 556,630 | 45.95M |
| 145 | BCAX | Bicara Therapeutics Inc. | 1.28B | 6.66% | 1,000,371 | - |
| 146 | OLMA | Olema Pharmaceuticals, Inc. | 1.26B | -25.75% | 13,980,012 | - |
| 147 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | 0.44% | 2,974,611 | 6.31M |
| 148 | PGEN | Precigen, Inc. | 1.24B | 5.72% | 2,559,728 | 6.31M |
| 149 | IVA | Inventiva S.A. | 1.18B | 4.08% | 227,517 | 19.93M |
| 150 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | -15.03% | 4,072,705 | - |
| 151 | QURE | uniQure N.V. | 1.12B | 26.07% | 15,400,566 | 16.10M |
| 152 | AVBP | ArriVent BioPharma, Inc. | 1.10B | 5.89% | 1,438,932 | - |
| 153 | PHAR | Pharming Group N.V. | 1.08B | 3.56% | 6,151 | 362.27M |
| 154 | ABCL | AbCellera Biologics Inc. | 1.07B | 2.03% | 1,977,804 | 75.13M |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.05B | 3.87% | 265,458 | 1.40M |
| 156 | GERN | Geron Corporation | 1.04B | 5.88% | 13,291,006 | 183.88M |
| 157 | SLS | SELLAS Life Sciences Group, Inc. | 1.01B | 7.78% | 9,793,284 | - |
| 158 | AKTS | Aktis Oncology, Inc. | 1.00B | 1.33% | 254,417 | 5.56M |
| 159 | GHRS | GH Research PLC | 991.23M | 0.31% | 334,428 | - |
| 160 | CMPX | Compass Therapeutics, Inc. | 976.08M | -1.63% | 1,896,961 | 850.00K |
| 161 | URGN | UroGen Pharma Ltd. | 969.26M | -2.69% | 878,828 | 109.79M |
| 162 | XERS | Xeris Biopharma Holdings, Inc. | 965.62M | -3.61% | 2,350,470 | 291.85M |
| 163 | VALN | Valneva SE | 942.29M | -0.19% | 6,088 | 211.09M |
| 164 | MRVI | Maravai LifeSciences Holdings, Inc. | 933.15M | 2.25% | 3,030,738 | 185.74M |
| 165 | FTRE | Fortrea Holdings Inc. | 919.11M | 2.29% | 1,857,558 | 2.72B |
| 166 | ABUS | Arbutus Biopharma Corporation | 907.77M | 4.19% | 3,790,390 | 14.61M |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 904.46M | -2.73% | 865,878 | - |
| 168 | SGP | SpyGlass Pharma, Inc. | 903.57M | 1.20% | 187,040 | - |
| 169 | SPRY | ARS Pharmaceuticals, Inc. | 898.64M | -0.11% | 1,703,382 | 84.28M |
| 170 | SANA | Sana Biotechnology, Inc. | 888.67M | 5.71% | 2,909,095 | - |
| 171 | EVMN | Evommune, Inc. | 886.41M | -7.13% | 223,308 | 13.00M |
| 172 | PHAT | Phathom Pharmaceuticals, Inc. | 875.45M | 4.12% | 681,473 | 175.11M |
| 173 | KALV | KalVista Pharmaceuticals, Inc. | 874.45M | 6.59% | 2,017,131 | 1.43M |
| 174 | XNCR | Xencor, Inc. | 870.53M | 4.86% | 835,907 | 125.58M |
| 175 | MPLT | MapLight Therapeutics, Inc. | 863.66M | 6.92% | 201,956 | - |
| 176 | ARVN | Arvinas, Inc. | 855.16M | -1.69% | 591,045 | 262.60M |
| 177 | CTMX | CytomX Therapeutics, Inc. | 852.26M | 7.48% | 2,318,356 | 113.63M |
| 178 | JANX | Janux Therapeutics, Inc. | 850.43M | 1.01% | 971,854 | 10.00M |
| 179 | ANNX | Annexon, Inc. | 833.22M | 8.33% | 2,107,070 | - |
| 180 | KURA | Kura Oncology, Inc. | 829.42M | 4.80% | 2,186,201 | 67.48M |
| 181 | MNKD | MannKind Corporation | 825.71M | 2.68% | 6,619,767 | 348.97M |
| 182 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 825.14M | -1.06% | 151,318 | - |
| 183 | EIKN | Eikon Therapeutics, Inc. | 804.91M | 3.69% | 273,082 | - |
| 184 | OMER | Omeros Corporation | 800.47M | -2.17% | 1,019,182 | - |
| 185 | DRUG | Bright Minds Biosciences Inc. | 793.06M | 4.67% | 80,314 | - |
| 186 | GYRE | Gyre Therapeutics, Inc. | 741.67M | 5.84% | 156,457 | 107.27M |
| 187 | PRME | Prime Medicine, Inc. | 727.80M | 2.49% | 2,947,218 | 4.63M |
| 188 | PROK | ProKidney Corp. | 718.99M | 3.91% | 530,516 | 744.00K |
| 189 | REPL | Replimune Group, Inc. | 712.60M | 6.94% | 3,043,328 | - |
| 190 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | -1.75% | 3,642,071 | 49.80M |
| 191 | JBIO | Jade Biosciences, Inc. | 711.63M | 2.70% | 500,789 | - |
| 192 | TBPH | Theravance Biopharma, Inc. | 709.41M | 3.17% | 1,205,321 | 80.33M |
| 193 | AGMB | AgomAb Therapeutics NV | 703.27M | 5.95% | 68,550 | - |
| 194 | ANRO | Alto Neuroscience, Inc. | 683.15M | 5.92% | 327,617 | - |
| 195 | MDXG | MiMedx Group, Inc. | 670.04M | 0.22% | 1,233,890 | 418.63M |
| 196 | ZURA | Zura Bio Limited | 667.92M | 1.00% | 552,485 | - |
| 197 | VOR | Vor Biopharma Inc. | 641.90M | 2.25% | 572,095 | - |
| 198 | TECX | Tectonic Therapeutic, Inc. | 638.41M | -5.21% | 726,683 | - |
| 199 | SLDB | Solid Biosciences Inc. | 624.84M | 18.81% | 4,933,008 | - |
| 200 | LRMR | Larimar Therapeutics, Inc. | 617.88M | 9.00% | 3,552,339 | - |
| 201 | LBRX | LB Pharmaceuticals Inc | 615.78M | 2.35% | 168,690 | - |
| 202 | MGTX | MeiraGTx Holdings plc | 593.22M | 5.29% | 462,353 | 27.42M |
| 203 | DSGN | Design Therapeutics, Inc. | 590.71M | 3.38% | 163,251 | - |
| 204 | DRTS | Alpha Tau Medical Ltd. | 572.12M | 4.68% | 354,652 | - |
| 205 | ALLO | Allogene Therapeutics, Inc. | 561.83M | 8.70% | 5,604,134 | 22.00K |
| 206 | YDES | YD Bio Limited | 555.53M | -3.07% | 15,944 | 510.36K |
| 207 | RCKT | Rocket Pharmaceuticals, Inc. | 554.79M | 15.87% | 3,899,719 | - |
| 208 | VSTM | Verastem, Inc. | 553.36M | -1.25% | 1,696,077 | 30.91M |
| 209 | NMRA | Neumora Therapeutics, Inc. | 547.20M | 6.62% | 1,102,168 | - |
| 210 | OCGN | Ocugen, Inc. | 544.31M | 3.11% | 5,437,616 | 4.41M |
| 211 | LXEO | Lexeo Therapeutics, Inc. | 543.03M | 8.61% | 2,033,495 | - |
| 212 | LYEL | Lyell Immunopharma, Inc. | 541.72M | 13.54% | 237,462 | 41.00K |
| 213 | RGNX | REGENXBIO Inc. | 535.74M | 20.00% | 1,931,278 | 170.44M |
| 214 | IVVD | Invivyd, Inc. | 534.10M | 5.00% | 2,183,139 | 53.43M |
| 215 | IMMX | Immix Biopharma, Inc. | 533.81M | 9.04% | 1,002,188 | - |
| 216 | FULC | Fulcrum Therapeutics, Inc. | 528.81M | -2.82% | 1,034,339 | 80.00M |
| 217 | IPSC | Century Therapeutics, Inc. | 528.16M | 14.84% | 2,330,489 | 113.34M |
| 218 | PRTA | Prothena Corporation plc | 528.10M | 2.29% | 626,440 | 9.68M |
| 219 | RLMD | Relmada Therapeutics, Inc. | 525.80M | 61.12% | 43,004,611 | - |
| 220 | ADCT | ADC Therapeutics SA | 524.00M | 2.92% | 703,623 | 75.21M |
| 221 | CRMD | CorMedix Inc. | 518.57M | 1.55% | 2,720,813 | 311.71M |
| 222 | RIGL | Rigel Pharmaceuticals, Inc. | 518.54M | -2.77% | 561,346 | 294.28M |
| 223 | ZVRA | Zevra Therapeutics, Inc. | 513.43M | 1.56% | 1,965,861 | 106.47M |
| 224 | VNDA | Vanda Pharmaceuticals Inc. | 513.06M | 10.01% | 2,222,219 | 216.11M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 505.53M | -2.45% | 220,080 | - |
| 226 | ALT | Altimmune, Inc. | 504.67M | 9.60% | 5,337,005 | 41.00K |
| 227 | FBRX | Forte Biosciences, Inc. | 498.92M | -2.71% | 89,975 | - |
| 228 | AVIR | Atea Pharmaceuticals, Inc. | 489.98M | 4.41% | 974,047 | - |
| 229 | KYTX | Kyverna Therapeutics, Inc. | 479.89M | 3.70% | 870,764 | - |
| 230 | ENGN | enGene Holdings Inc. | 472.28M | -18.78% | 1,418,853 | - |
| 231 | EPRX | Eupraxia Pharmaceuticals Inc. | 471.96M | -2.13% | 134,781 | - |
| 232 | ASMB | Assembly Biosciences, Inc. | 460.75M | 3.01% | 103,230 | 37.19M |
| 233 | TRDA | Entrada Therapeutics, Inc. | 457.20M | 0.95% | 204,313 | 25.42M |
| 234 | VTVT | vTv Therapeutics Inc. | 453.17M | 3.13% | 58,375 | 17.00K |
| 235 | TENX | Tenax Therapeutics, Inc. | 447.09M | 3.09% | 531,586 | - |
| 236 | FDMT | 4D Molecular Therapeutics, Inc. | 445.30M | 2.95% | 552,919 | 120.00K |
| 237 | AVXL | Anavex Life Sciences Corp. | 443.90M | 3.01% | 900,577 | - |
| 238 | LCTX | Lineage Cell Therapeutics, Inc. | 440.88M | -4.32% | 1,292,801 | 14.56M |
| 239 | UPB | Upstream Bio, Inc. | 435.55M | 5.22% | 1,194,595 | 2.80M |
| 240 | AUTL | Autolus Therapeutics plc | 431.15M | 7.28% | 2,306,926 | 51.13M |
| 241 | STTK | Shattuck Labs, Inc. | 430.82M | 0.50% | 836,839 | 1.00M |
| 242 | BNTC | Benitec Biopharma Inc. | 429.90M | 10.67% | 417,082 | - |
| 243 | ARMP | Armata Pharmaceuticals, Inc. | 422.68M | 9.53% | 24,338 | 5.05M |
| 244 | DMAC | DiaMedica Therapeutics Inc. | 417.38M | 1.04% | 117,775 | - |
| 245 | NAGE | Niagen Bioscience, Inc. | 410.06M | 0.99% | 2,794,822 | 129.42M |
| 246 | STRO | Sutro Biopharma, Inc. | 409.37M | -1.23% | 302,702 | 105.65M |
| 247 | ACRS | Aclaris Therapeutics, Inc. | 408.82M | 10.78% | 13,708,317 | 7.83M |
| 248 | IMMP | Immutep Limited | 408.45M | - | 5 | 5.28M |
| 249 | NBP | NovaBridge Biosciences | 404.10M | 0.14% | 1,566,114 | - |
| 250 | ENTA | Enanta Pharmaceuticals, Inc. | 403.08M | 2.58% | 130,587 | 66.98M |
| 251 | CBIO | Crescent Biopharma, Inc. | 399.23M | -0.41% | 68,281 | 10.84M |
| 252 | PRTC | PureTech Health plc | 395.82M | -2.38% | 4,319 | 6.39M |
| 253 | MNPR | Monopar Therapeutics Inc. | 388.06M | 0.80% | 158,998 | - |
| 254 | LENZ | LENZ Therapeutics, Inc. | 384.87M | 5.40% | 807,881 | 17.50M |
| 255 | DNA | Ginkgo Bioworks Holdings, Inc. | 384.75M | 1.69% | 819,459 | 170.16M |
| 256 | PEPG | PepGen Inc. | 383.63M | -2.11% | 495,488 | - |
| 257 | ABSI | Absci Corporation | 377.43M | 5.46% | 5,383,000 | 2.82M |
| 258 | CADL | Candel Therapeutics, Inc. | 375.76M | 3.85% | 1,830,773 | - |
| 259 | BCYC | Bicycle Therapeutics plc | 373.20M | 3.46% | 664,444 | 28.34M |
| 260 | NGNE | Neurogene Inc. | 365.56M | 6.45% | 102,712 | 925.00K |
| 261 | IMRX | Immuneering Corporation | 362.88M | 5.44% | 1,037,315 | - |
| 262 | XFOR | X4 Pharmaceuticals, Inc. | 362.86M | 10.37% | 590,490 | 33.98M |
| 263 | AURA | Aura Biosciences, Inc. | 360.06M | 1.25% | 171,877 | - |
| 264 | GLSI | Greenwich LifeSciences, Inc. | 356.89M | 11.56% | 174,497 | - |
| 265 | CCCC | C4 Therapeutics, Inc. | 350.31M | 18.09% | 6,580,722 | 35.95M |
| 266 | CLYM | Climb Bio, Inc. | 346.32M | 0.97% | 537,299 | - |
| 267 | NERV | Minerva Neurosciences, Inc. | 346.20M | 33.11% | 588,440 | - |
| 268 | RZLT | Rezolute, Inc. | 338.62M | 4.82% | 1,983,581 | - |
| 269 | IRD | Opus Genetics, Inc. | 328.96M | -2.45% | 1,220,138 | 14.63M |
| 270 | XOMA | XOMA Royalty Corporation | 326.34M | 5.66% | 278,201 | 47.11M |
| 271 | CAMP | Camp4 Therapeutics Corporation | 325.79M | 49.40% | 5,920,278 | 3.50M |
| 272 | ANL | Adlai Nortye Ltd. | 324.35M | -1.35% | 143,615 | -1.35M |
| 273 | FHTX | Foghorn Therapeutics Inc. | 321.03M | -5.19% | 190,742 | 24.52M |
| 274 | AVTX | Avalo Therapeutics, Inc. | 320.46M | 0.23% | 531,970 | 192.00K |
| 275 | NAUT | Nautilus Biotechnology, Inc. | 317.68M | 1.62% | 248,594 | - |
| 276 | ALDX | Aldeyra Therapeutics, Inc. | 316.56M | 9.58% | 1,426,513 | - |
| 277 | PBYI | Puma Biotechnology, Inc. | 316.45M | 2.81% | 377,221 | 228.37M |
| 278 | CABA | Cabaletta Bio, Inc. | 314.79M | 3.15% | 1,612,279 | - |
| 279 | TARA | Protara Therapeutics, Inc. | 308.13M | -2.54% | 1,173,571 | - |
| 280 | SLN | Silence Therapeutics plc | 292.38M | -0.64% | 329,254 | 559.00K |
| 281 | CHRS | Coherus Oncology, Inc. | 288.48M | 6.04% | 2,233,921 | 42.17M |
| 282 | ACIU | AC Immune SA | 282.98M | 2.51% | 221,536 | 5.48M |
| 283 | OABI | OmniAb, Inc. | 282.33M | 3.17% | 356,315 | 18.67M |
| 284 | ABEO | Abeona Therapeutics Inc. | 279.63M | 6.39% | 1,939,265 | 400.00K |
| 285 | ALXO | ALX Oncology Holdings Inc. | 279.45M | -2.94% | 647,373 | - |
| 286 | OVID | Ovid Therapeutics Inc. | 278.59M | 12.04% | 7,516,623 | 6.61M |
| 287 | HELP | Cybin Inc. | 276.20M | 5.14% | 1,118,588 | - |
| 288 | ENLV | Enlivex Ltd. | 275.36M | 1.75% | 98,258 | - |
| 289 | CLLS | Cellectis S.A. | 273.34M | 1.97% | 166,023 | 82.55M |
| 290 | CNTX | Context Therapeutics Inc. | 266.45M | -7.05% | 1,369,518 | - |
| 291 | OBIO | Orchestra BioMed Holdings, Inc. | 263.69M | 8.10% | 133,928 | 2.82M |
| 292 | PALI | Palisade Bio, Inc. | 259.27M | 6.75% | 2,673,784 | - |
| 293 | FENC | Fennec Pharmaceuticals Inc. | 259.23M | -1.43% | 168,351 | 38.79M |
| 294 | IKT | Inhibikase Therapeutics, Inc. | 258.52M | 0.53% | 1,295,883 | 1.00 |
| 295 | SRZN | Surrozen, Inc. | 255.44M | 0.18% | 49,156 | 3.60M |
| 296 | PRLD | Prelude Therapeutics Incorporated | 254.61M | -4.33% | 285,422 | 10.50M |
| 297 | CBUS | Cibus, Inc. | 248.61M | 16.46% | 386,316 | 3.79M |
| 298 | ALEC | Alector, Inc. | 241.69M | 9.50% | 938,983 | 21.05M |
| 299 | NVCT | Nuvectis Pharma, Inc. | 240.54M | 1.34% | 44,488 | - |
| 300 | SLGL | Sol-Gel Technologies Ltd. | 236.76M | 4.09% | 32,076 | 18.97M |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 234.55M | 31.68% | 2,932,269 | 2.80M |
| 302 | PLX | Protalix BioTherapeutics, Inc. | 231.61M | 9.92% | 1,440,621 | 61.84M |
| 303 | HUMA | Humacyte, Inc. | 231.60M | 8.11% | 6,595,827 | 1.57M |
| 304 | ELDN | Eledon Pharmaceuticals, Inc. | 230.12M | 4.32% | 2,293,675 | - |
| 305 | CNTN | Canton Strategic Holdings, Inc. | 229.26M | -0.67% | 600,743 | - |
| 306 | VYGR | Voyager Therapeutics, Inc. | 228.52M | 5.38% | 487,001 | 40.37M |
| 307 | EDIT | Editas Medicine, Inc. | 226.48M | 16.00% | 4,948,233 | 40.52M |
| 308 | MDWD | MediWound Ltd. | 224.67M | 2.70% | 168,354 | 16.96M |
| 309 | ACHV | Achieve Life Sciences, Inc. | 224.65M | -1.17% | 342,508 | - |
| 310 | KROS | Keros Therapeutics, Inc. | 223.79M | 0.44% | 683,303 | 244.06M |
| 311 | GALT | Galectin Therapeutics Inc. | 215.98M | 8.06% | 737,627 | - |
| 312 | PMN | ProMIS Neurosciences, Inc. | 213.16M | 1.58% | 38,132 | - |
| 313 | ARCT | Arcturus Therapeutics Holdings Inc. | 209.19M | 3.52% | 491,328 | 82.03M |
| 314 | TNYA | Tenaya Therapeutics, Inc. | 207.33M | 7.84% | 13,826,326 | - |
| 315 | ELTX | Elicio Therapeutics, Inc. | 205.86M | 1.29% | 144,679 | - |
| 316 | CGEN | Compugen Ltd. | 203.29M | 3.37% | 234,810 | 72.76M |
| 317 | PRQR | ProQR Therapeutics N.V. | 199.10M | 6.18% | 649,210 | 18.86M |
| 318 | NTHI | NeOnc Technologies Holdings, Inc. | 193.40M | 2.75% | 44,453 | 59.99K |
| 319 | WHWK | Whitehawk Therapeutics, Inc. | 192.28M | 8.80% | 323,096 | 14.38M |
| 320 | CRBU | Caribou Biosciences, Inc. | 190.38M | 8.24% | 1,634,567 | 11.16M |
| 321 | ABOS | Acumen Pharmaceuticals, Inc. | 190.20M | -5.14% | 306,478 | - |
| 322 | HRTX | Heron Therapeutics, Inc. | 187.88M | 3.09% | 1,651,219 | 154.90M |
| 323 | VXRT | Vaxart, Inc. | 187.27M | 5.62% | - | 148.20M |
| 324 | KLRS | Kalaris Therapeutics, Inc. | 187.02M | 1.83% | 44,725 | - |
| 325 | NKTX | Nkarta, Inc. | 183.26M | 3.20% | 667,680 | - |
| 326 | SABS | SAB Biotherapeutics, Inc. | 182.81M | 1.32% | 174,985 | 114.70K |
| 327 | MENS | Jyong Biotech Ltd. | 180.72M | 8.80% | 191,008 | - |
| 328 | TNXP | Tonix Pharmaceuticals Holding Corp. | 178.35M | 3.64% | 313,552 | 10.30M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 176.95M | 19.23% | 515,933 | - |
| 330 | TLSA | Tiziana Life Sciences Ltd | 176.12M | -0.72% | 80,138 | - |
| 331 | MOLN | Molecular Partners AG | 175.48M | -2.00% | 2,346 | 856.30K |
| 332 | SGMT | Sagimet Biosciences Inc. | 174.97M | -0.55% | 348,324 | - |
| 333 | MIST | Milestone Pharmaceuticals Inc. | 169.64M | 5.70% | 2,004,752 | - |
| 334 | RANI | Rani Therapeutics Holdings, Inc. | 167.70M | 6.15% | 725,962 | 1.20M |
| 335 | PLYX | Polaryx Therapeutics, Inc. | 166.65M | 28.47% | 769,984 | - |
| 336 | IMUX | Immunic, Inc. | 163.08M | 1.63% | 1,947,113 | - |
| 337 | ZNTL | Zentalis Pharmaceuticals, Inc. | 160.58M | 8.06% | 518,598 | 26.87M |
| 338 | KPTI | Karyopharm Therapeutics Inc. | 155.74M | -3.19% | 735,621 | 146.07M |
| 339 | FATE | Fate Therapeutics, Inc. | 154.63M | - | 1,369,525 | 6.65M |
| 340 | SGMO | Sangamo Therapeutics, Inc. | 152.47M | 8.66% | 4,281,130 | 32.88M |
| 341 | UNCY | Unicycive Therapeutics, Inc. | 151.51M | 6.98% | 541,614 | - |
| 342 | IPHA | Innate Pharma S.A. | 149.94M | -1.25% | 5,024 | 14.84M |
| 343 | MGNX | MacroGenics, Inc. | 149.29M | 5.83% | 1,083,850 | 127.63M |
| 344 | CNTB | Connect Biopharma Holdings Limited | 148.14M | 6.85% | 217,880 | 762.00K |
| 345 | ANTX | AN2 Therapeutics, Inc. | 143.86M | 84.21% | 57,966,725 | - |
| 346 | ADAG | Adagene Inc. | 143.75M | 5.63% | 34,572 | 103.20K |
| 347 | ARTV | Artiva Biotherapeutics, Inc. | 140.15M | -0.52% | 109,504 | 251.00K |
| 348 | CRDF | Cardiff Oncology, Inc. | 136.05M | 5.85% | 1,062,498 | 593.00K |
| 349 | AARD | Aardvark Therapeutics, Inc. | 132.60M | 4.10% | 320,322 | - |
| 350 | SPRO | Spero Therapeutics, Inc. | 130.71M | 0.87% | 377,519 | 40.55M |
| 351 | ORMP | Oramed Pharmaceuticals Inc. | 129.76M | -0.76% | 115,138 | 2.00M |
| 352 | GOSS | Gossamer Bio, Inc. | 128.53M | 10.90% | 9,228,088 | 44.05M |
| 353 | ACOG | Alpha Cognition Inc. | 127.63M | 1.38% | 11,943 | 7.43M |
| 354 | GNLX | Genelux Corporation | 125.33M | 4.43% | 134,535 | 8.00K |
| 355 | BDTX | Black Diamond Therapeutics, Inc. | 124.21M | 1.40% | 869,033 | 70.00M |
| 356 | EQ | Equillium, Inc. | 123.00M | 14.12% | 921,771 | 4.39M |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 118.86M | -0.57% | 772,381 | 182.34K |
| 358 | KRRO | Korro Bio, Inc. | 115.83M | 10.02% | 942,878 | 7.37M |
| 359 | ONCY | Oncolytics Biotech Inc. | 114.06M | - | 1,720,541 | - |
| 360 | COYA | Coya Therapeutics, Inc. | 113.48M | 1.04% | 87,598 | 3.99M |
| 361 | DTIL | Precision BioSciences, Inc. | 113.38M | 2.17% | 569,975 | 698.00K |
| 362 | CDXS | Codexis, Inc. | 112.91M | 1.63% | 1,125,723 | 52.93M |
| 363 | GANX | Gain Therapeutics, Inc. | 112.69M | -3.93% | 1,083,624 | - |
| 364 | AGEN | Agenus Inc. | 107.13M | 6.42% | 453,969 | 106.83M |
| 365 | FBIO | Fortress Biotech, Inc. | 104.60M | 0.90% | 528,769 | 62.30M |
| 366 | HURA | TuHURA Biosciences, Inc. | 102.62M | 12.67% | 912,582 | - |
| 367 | SAVA | Cassava Sciences, Inc. | 102.41M | 4.43% | 615,290 | - |
| 368 | TTRX | Turn Therapeutics Inc. | 102.17M | -0.86% | 24,952 | - |
| 369 | SEER | Seer, Inc. | 102.12M | 1.40% | 455,918 | 16.58M |
| 370 | DWTX | Dogwood Therapeutics, Inc. | 101.88M | 5.88% | 48,831 | - |
| 371 | BMEA | Biomea Fusion, Inc. | 100.40M | 2.16% | 1,413,321 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 99.47M | 4.56% | 128,683 | - |
| 373 | CGTX | Cognition Therapeutics, Inc. | 95.34M | 4.85% | 882,568 | - |
| 374 | VANI | Vivani Medical, Inc. | 93.43M | - | 116,779 | - |
| 375 | PYXS | Pyxis Oncology, Inc. | 93.40M | 9.49% | 453,863 | 2.82M |
| 376 | VRCA | Verrica Pharmaceuticals Inc. | 90.82M | 6.97% | 236,771 | 30.83M |
| 377 | KZIA | Kazia Therapeutics Limited | 89.57M | -0.36% | 66,430 | 1.20M |
| 378 | ATYR | aTyr Pharma, Inc. | 88.21M | 9.17% | 1,556,271 | 190.00K |
| 379 | OKYO | OKYO Pharma Limited | 87.84M | 3.01% | 175,003 | - |
| 380 | MAIA | MAIA Biotechnology, Inc. | 87.40M | -3.25% | 868,164 | - |
| 381 | PMVP | PMV Pharmaceuticals, Inc. | 86.93M | -0.61% | 892,736 | - |
| 382 | IBIO | iBio, Inc. | 86.36M | -4.21% | 1,624,698 | 300.00K |
| 383 | SPRB | Spruce Biosciences, Inc. | 85.22M | 11.17% | 77,079 | 697.00K |
| 384 | MCRB | Seres Therapeutics, Inc. | 84.31M | 2.08% | 60,372 | 351.00K |
| 385 | CSBR | Champions Oncology, Inc. | 82.90M | 1.70% | 2,831 | 58.42M |
| 386 | PLRX | Pliant Therapeutics, Inc. | 80.81M | -1.13% | 356,884 | - |
| 387 | PYPD | PolyPid Ltd. | 79.77M | -0.24% | 34,654 | - |
| 388 | ACET | Adicet Bio, Inc. | 76.91M | 4.39% | 93,711 | - |
| 389 | GUTS | Fractyl Health, Inc. | 75.00M | 1.88% | 1,978,746 | 3.00K |
| 390 | PTHS | Pelthos Therapeutics Inc. | 74.58M | -0.30% | 1,161 | 7.41M |
| 391 | COEP | Coeptis Therapeutics Holdings, Inc. | 72.31M | -3.49% | 138,074 | 501.00K |
| 392 | XBIT | XBiotech Inc. | 71.65M | - | 27,866 | - |
| 393 | CING | Cingulate Inc. | 71.37M | 6.53% | 417,084 | - |
| 394 | QTTB | Q32 Bio Inc. | 71.25M | 8.51% | 233,123 | - |
| 395 | TCRX | TScan Therapeutics, Inc. | 70.56M | 10.71% | 1,351,517 | 10.33M |
| 396 | ACTU | Actuate Therapeutics, Inc. | 68.45M | 3.50% | 91,361 | - |
| 397 | ANVS | Annovis Bio, Inc. | 68.11M | 3.21% | 400,190 | - |
| 398 | MNOV | MediciNova, Inc. | 67.93M | 1.47% | 73,872 | 409.66K |
| 399 | IBO | Impact BioMedical Inc. | 66.84M | -4.98% | 1,396,177 | 25.00K |
| 400 | IFRX | InflaRx N.V. | 64.44M | -1.94% | 191,838 | 73.73K |
| 401 | IMA | ImageneBio, Inc. | 63.05M | 1.37% | 18,894 | 800.00K |
| 402 | MREO | Mereo BioPharma Group plc | 62.32M | -0.63% | 885,314 | 500.00K |
| 403 | EXOZ | eXoZymes, Inc. | 61.83M | 0.68% | 2,618 | -700.00 |
| 404 | ATHE | Alterity Therapeutics Limited | 61.33M | 3.50% | 6,039 | 4.43M |
| 405 | NRXS | NeurAxis, Inc. | 61.25M | 0.70% | 68,151 | 3.36M |
| 406 | ENTX | Entera Bio Ltd. | 60.99M | 6.40% | 75,006 | 124.00K |
| 407 | GRCE | Grace Therapeutics, Inc. | 60.81M | 1.81% | 252,275 | - |
| 408 | TIL | Instil Bio, Inc. | 60.36M | 0.34% | 30,194 | - |
| 409 | BYSI | BeyondSpring Inc. | 60.24M | 1.03% | 26,441 | 1.88M |
| 410 | OSTX | OS Therapies Incorporated | 60.22M | 8.92% | 1,763,575 | - |
| 411 | MGX | Metagenomi Therapeutics, Inc. | 60.19M | 8.11% | 328,991 | 25.21M |
| 412 | EDSA | Edesa Biotech, Inc. | 59.61M | 9.51% | 6,173,813 | - |
| 413 | ICCC | ImmuCell Corporation | 58.62M | -1.82% | 12,590 | 27.64M |
| 414 | LONA | LeonaBio, Inc. | 57.60M | 16.42% | 39,260 | - |
| 415 | RADX | Radiopharm Theranostics Limited | 57.46M | -1.00% | 134,908 | 10.86M |
| 416 | RLYB | Rallybio Corporation | 56.94M | -1.33% | 181,630 | 674.00K |
| 417 | NRXP | NRx Pharmaceuticals, Inc. | 55.14M | 1.76% | 743,662 | 242.00K |
| 418 | PSTV | Plus Therapeutics, Inc. | 52.22M | 2.25% | 3,676,998 | 5.26M |
| 419 | NTRB | Nutriband Inc. | 51.66M | -2.52% | 3,027 | 2.28M |
| 420 | HYFT | MindWalk Holdings Corp. | 51.36M | -0.90% | 762,894 | 19.02M |
| 421 | KZR | Kezar Life Sciences, Inc. | 51.26M | 0.86% | 6,247 | - |
| 422 | KLTO | Klotho Neurosciences, Inc. | 50.92M | 2.73% | 2,526,698 | - |
| 423 | ACRV | Acrivon Therapeutics, Inc. | 50.49M | 3.23% | 805,354 | - |
| 424 | INKT | MiNK Therapeutics, Inc. | 49.05M | 1.65% | 4,382 | - |
| 425 | ATRA | Atara Biotherapeutics, Inc. | 48.16M | 29.21% | 3,222,713 | 151.93M |
| 426 | ESLA | Estrella Immunopharma, Inc. | 47.08M | 4.67% | 57,383 | - |
| 427 | OKUR | OnKure Therapeutics, Inc. | 46.06M | 11.48% | 369,337 | - |
| 428 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | 6.40% | 52,221 | - |
| 429 | NXTC | NextCure, Inc. | 44.54M | 0.97% | 13,445 | - |
| 430 | LSTA | Lisata Therapeutics, Inc. | 44.46M | 20.57% | 448,441 | 1.07M |
| 431 | LPCN | Lipocine Inc. | 43.75M | -3.08% | 27,178 | 4.32M |
| 432 | LITS | Lite Strategy, Inc. | 43.63M | 5.26% | 513,640 | - |
| 433 | ALGS | Aligos Therapeutics, Inc. | 43.47M | 0.64% | 37,320 | 2.19M |
| 434 | APLM | Apollomics, Inc. | 42.92M | -0.30% | 5,551 | 6.93M |
| 435 | CRVO | CervoMed Inc. | 42.01M | 10.46% | 316,370 | 6.16M |
| 436 | PTN | Palatin Technologies, Inc. | 39.98M | -4.25% | 9,263 | 8.96M |
| 437 | XLO | Xilio Therapeutics, Inc. | 39.67M | 1.89% | 556,505 | 31.80M |
| 438 | VERU | Veru Inc. | 39.48M | -0.40% | 64,018 | 16.89M |
| 439 | ATOS | Atossa Therapeutics, Inc. | 39.35M | 0.88% | 129,931 | - |
| 440 | PDSB | PDS Biotechnology Corporation | 37.49M | 1.81% | 266,682 | - |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 37.44M | - | 51,780 | 90.00K |
| 442 | TVRD | Tvardi Therapeutics, Inc. | 37.34M | 1.27% | 21,129 | - |
| 443 | SNSE | Sensei Biotherapeutics, Inc. | 37.33M | -1.67% | 165,001 | - |
| 444 | OTLK | Outlook Therapeutics, Inc. | 37.18M | 8.12% | 1,674,222 | 205.70K |
| 445 | JSPR | Jasper Therapeutics, Inc. | 36.66M | -5.07% | 378,675 | - |
| 446 | ABVC | ABVC BioPharma, Inc. | 36.08M | 8.96% | 75,109 | 797.92K |
| 447 | CELU | Celularity Inc. | 36.05M | 3.31% | 17,471 | 40.58M |
| 448 | HOWL | Werewolf Therapeutics, Inc. | 35.57M | 15.95% | 1,540,136 | 1.14M |
| 449 | INMB | INmune Bio Inc. | 34.83M | -1.50% | 866,837 | 50.00K |
| 450 | PLUR | Pluri Inc. | 33.87M | 2.74% | 11,910 | 1.34M |
| 451 | NBY | NovaBay Pharmaceuticals, Inc. | 32.39M | -10.79% | 514,293 | 10.30M |
| 452 | TPST | Tempest Therapeutics, Inc. | 32.22M | 3.46% | 74,144 | - |
| 453 | RNTX | Rein Therapeutics Inc. | 31.54M | 0.83% | 109,037 | - |
| 454 | TVGN | Tevogen Bio Holdings Inc. | 31.37M | 6.02% | 65,901 | - |
| 455 | CVM | CEL-SCI Corporation | 31.32M | -1.78% | 20,292 | - |
| 456 | LTRN | Lantern Pharma Inc. | 30.65M | 1.48% | 45,349 | - |
| 457 | KYNB | Kyntra Bio, Inc. | 29.69M | 7.31% | 56,878 | 8.30M |
| 458 | CUE | Cue Biopharma, Inc. | 29.34M | 0.40% | 613,640 | 7.10M |
| 459 | RNXT | RenovoRx, Inc. | 29.33M | 1.27% | 155,895 | 928.00K |
| 460 | DYAI | Dyadic International, Inc. | 28.95M | 4.22% | 310,302 | 3.34M |
| 461 | HYPD | Hyperion DeFi, Inc. | 28.55M | 9.32% | 447,015 | 345.32K |
| 462 | PASG | Passage Bio, Inc. | 28.20M | 4.64% | 26,265 | - |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 28.07M | -2.96% | 211,743 | - |
| 464 | IGC | IGC Pharma, Inc. | 27.77M | 1.36% | 302,301 | 1.11M |
| 465 | BCTX | BriaCell Therapeutics Corp. | 27.09M | -2.59% | 375,100 | - |
| 466 | AEON | AEON Biopharma, Inc. | 27.07M | 0.94% | 129,705 | - |
| 467 | FBLG | FibroBiologics, Inc. | 27.05M | -8.00% | 973,125 | - |
| 468 | XCUR | Exicure, Inc. | 26.07M | -1.44% | 6,288 | 500.00K |
| 469 | EVAX | Evaxion A/S | 25.69M | -4.35% | 33,713 | 7.53M |
| 470 | SNTI | Senti Biosciences, Inc. | 25.57M | 0.81% | 229,337 | - |
| 471 | BOLD | Boundless Bio, Inc. | 25.52M | 0.88% | 76,472 | - |
| 472 | MRKR | Marker Therapeutics, Inc. | 24.51M | 6.52% | 219,026 | 4.69M |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 24.47M | 5.09% | 110,347 | 14.99M |
| 474 | VTGN | Vistagen Therapeutics, Inc. | 24.37M | 1.20% | 447,990 | 789.00K |
| 475 | SKYE | Skye Bioscience, Inc. | 23.21M | 0.50% | 195,759 | - |
| 476 | BRNS | Barinthus Biotherapeutics plc | 22.95M | -6.78% | 13,463 | 14.97M |
| 477 | LIXT | Lixte Biotechnology Holdings, Inc. | 21.87M | 2.87% | 50,816 | - |
| 478 | DARE | Daré Bioscience, Inc. | 21.86M | - | 73,241 | -57.13K |
| 479 | NNVC | NanoViricides, Inc. | 21.16M | 2.12% | 273,360 | - |
| 480 | PLRZ | Polyrizon Ltd. | 20.69M | -0.99% | 8,452 | - |
| 481 | IOBT | IO Biotech, Inc. | 20.15M | -6.82% | 2,179,458 | - |
| 482 | GNTA | Genenta Science S.p.A. | 20.09M | -0.31% | 16,967 | - |
| 483 | ALLR | Allarity Therapeutics, Inc. | 19.94M | - | 741,127 | - |
| 484 | INTS | Intensity Therapeutics, Inc. | 19.69M | -2.26% | 23,140 | - |
| 485 | VYNE | VYNE Therapeutics Inc. | 19.67M | -0.82% | 70,112 | 570.00K |
| 486 | CTXR | Citius Pharmaceuticals, Inc. | 18.77M | 0.47% | 475,160 | 3.94M |
| 487 | CVKD | Cadrenal Therapeutics, Inc. | 18.71M | -3.62% | 21,807 | - |
| 488 | KTTA | Pasithea Therapeutics Corp. | 18.47M | 0.44% | 127,010 | - |
| 489 | LEXX | Lexaria Bioscience Corp. | 18.16M | -11.98% | 222,153 | 522.00K |
| 490 | INAB | IN8bio, Inc. | 17.29M | 2.91% | 46,528 | - |
| 491 | SER | Serina Therapeutics, Inc. | 17.15M | 3.92% | 61,263 | 116.00K |
| 492 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 16.83M | -19.37% | 492,465 | - |
| 493 | HOTH | Hoth Therapeutics, Inc. | 15.36M | -0.27% | 128,534 | - |
| 494 | JUNS | Jupiter Neurosciences, Inc. | 14.60M | 9.61% | 122,415 | - |
| 495 | COCP | Cocrystal Pharma, Inc. | 14.20M | 1.98% | 49,239 | - |
| 496 | QNRX | Quoin Pharmaceuticals, Ltd. | 14.19M | -2.77% | 12,387 | - |
| 497 | CRIS | Curis, Inc. | 14.10M | 4.04% | 77,362 | 11.65M |
| 498 | BCAB | BioAtla, Inc. | 14.04M | 12.69% | 1,305,348 | 11.00M |
| 499 | BCDA | BioCardia, Inc. | 13.58M | 8.47% | 227,567 | 3.00K |
| 500 | TRAW | Traws Pharma, Inc. | 13.34M | 4.37% | 32,537 | 2.85M |
| 501 | GTBP | GT Biopharma, Inc. | 13.16M | -11.14% | 1,037,615 | - |
| 502 | KAPA | Kairos Pharma, Ltd. | 13.14M | 0.19% | 117,515 | - |
| 503 | PHIO | Phio Pharmaceuticals Corp. | 13.02M | 4.31% | 390,743 | - |
| 504 | QNTM | Quantum BioPharma Ltd. | 12.94M | -4.00% | 37,434 | - |
| 505 | OSRH | OSR Holdings, Inc. | 12.88M | -2.28% | 1,092,666 | -90.52K |
| 506 | NCEL | NewcelX Ltd. | 12.49M | -1.08% | 126,131 | - |
| 507 | CMMB | Chemomab Therapeutics Ltd. | 12.31M | 6.38% | 46,230 | - |
| 508 | GDTC | CytoMed Therapeutics Limited | 12.23M | 0.95% | 6,860 | 573.19K |
| 509 | SNGX | Soligenix, Inc. | 12.10M | 0.84% | 92,174 | 2.34K |
| 510 | PHGE | BiomX Inc. | 11.83M | 8.96% | 122,231 | - |
| 511 | BLRX | BioLineRx Ltd. | 11.78M | -0.38% | 21,718 | 12.74M |
| 512 | CLRB | Cellectar Biosciences, Inc. | 11.66M | -0.72% | 114,446 | - |
| 513 | CALC | CalciMedica, Inc. | 11.51M | 0.56% | 313,554 | - |
| 514 | AKTX | Akari Therapeutics, Plc | 11.37M | - | 71,237 | - |
| 515 | LGVN | Longeveron Inc. | 11.30M | 9.49% | 243,314 | 1.44M |
| 516 | IMNN | Imunon, Inc. | 10.61M | -3.70% | 11,316 | - |
| 517 | LIMN | Liminatus Pharma, Inc. | 10.48M | 0.56% | 949,258 | - |
| 518 | BIVI | BioVie Inc. | 10.41M | 1.47% | 44,698 | - |
| 519 | MBRX | Moleculin Biotech, Inc. | 9.67M | -5.77% | 463,824 | - |
| 520 | ICU | SeaStar Medical Holding Corporation | 9.52M | 4.76% | 28,251 | 881.00K |
| 521 | ITRM | Iterum Therapeutics plc | 9.45M | 8.04% | 756,573 | 390.00K |
| 522 | CLGN | CollPlant Biotechnologies Ltd. | 9.07M | 3.96% | 10,174 | 2.48M |
| 523 | CDIO | Cardio Diagnostics Holdings, Inc. | 8.87M | -8.30% | 578,142 | 15.78K |
| 524 | RNAZ | TransCode Therapeutics, Inc. | 8.87M | 0.73% | 12,184 | - |
| 525 | TOVX | Theriva Biologics, Inc. | 8.40M | 1.27% | 1,074,896 | - |
| 526 | TCRT | Alaunos Therapeutics, Inc. | 8.15M | 1.11% | 10,536 | 6.00K |
| 527 | NCNA | NuCana plc | 8.12M | -9.72% | 69,141 | - |
| 528 | ALZN | Alzamend Neuro, Inc. | 7.99M | 6.06% | 103,676 | - |
| 529 | BOLT | Bolt Biotherapeutics, Inc. | 7.91M | -4.19% | 43,870 | 5.20M |
| 530 | KPRX | Kiora Pharmaceuticals, Inc. | 7.85M | 8.08% | 33,236 | 20.00K |
| 531 | ERNA | Ernexa Therapeutics Inc. | 7.67M | -0.70% | 879,700 | 1,000.00 |
| 532 | PMCB | PharmaCyte Biotech, Inc. | 7.52M | -7.03% | 123,429 | - |
| 533 | PULM | Pulmatrix, Inc. | 7.49M | 1.49% | 46,954 | 3.00K |
| 534 | IMRN | Immuron Limited | 7.37M | -5.13% | 33,919 | 4.99M |
| 535 | KALA | KALA BIO, Inc. | 7.36M | -6.33% | 1,279,940 | - |
| 536 | GRDX | GridAI Technologies Corp. | 7.16M | -3.18% | 55,779 | - |
| 537 | ADXN | Addex Therapeutics Ltd | 6.73M | 0.42% | 585 | 198.82K |
| 538 | APVO | Aptevo Therapeutics Inc. | 6.72M | 5.23% | 10,673 | - |
| 539 | XTLB | XTL Biopharmaceuticals Ltd. | 6.71M | -3.58% | 10,931 | 968.00K |
| 540 | MBIO | Mustang Bio, Inc. | 6.71M | 2.54% | 23,742 | - |
| 541 | CELZ | Creative Medical Technology Holdings, Inc. | 6.67M | 1.60% | 29,855 | 6.00K |
| 542 | EVGN | Evogene Ltd. | 6.67M | -0.36% | 52,871 | 8.02M |
| 543 | APM | Aptorum Group Limited | 6.51M | - | 14,816 | - |
| 544 | MLEC | Moolec Science SA | 6.51M | -4.06% | 244,087 | 7.83M |
| 545 | PCSA | Processa Pharmaceuticals, Inc. | 6.34M | -1.06% | 6,292 | - |
| 546 | SLXN | Silexion Therapeutics Corp | 6.13M | 13.29% | 83,779 | - |
| 547 | ASBP | Aspire Biopharma Holdings, Inc. | 6.03M | 3.45% | 88,787 | 1.94K |
| 548 | PPBT | Purple Biotech Ltd | 6.02M | -4.92% | 14,478 | - |
| 549 | QNCX | Quince Therapeutics, Inc. | 5.93M | 4.11% | 23,139,039 | - |
| 550 | APRE | Aprea Therapeutics, Inc. | 5.91M | -6.15% | 102,645 | 488.24K |
| 551 | PBM | Psyence Biomedical Ltd. | 5.85M | 1.59% | 24,607 | - |
| 552 | CYCN | Cyclerion Therapeutics, Inc. | 5.67M | 5.67% | 54,528 | 2.86M |
| 553 | CANF | Can-Fite BioPharma Ltd. | 5.45M | -10.33% | 251,980 | 560.00K |
| 554 | LNAI | Lunai Bioworks Inc. | 5.32M | -5.25% | 1,068,324 | - |
| 555 | XBIO | Xenetic Biosciences, Inc. | 5.29M | 0.87% | 5,570 | 2.86M |
| 556 | GOVX | GeoVax Labs, Inc. | 5.04M | 7.26% | 119,990 | 3.35M |
| 557 | ACXP | Acurx Pharmaceuticals, Inc. | 4.98M | 44.81% | 7,552,311 | - |
| 558 | BRTX | BioRestorative Therapies, Inc. | 4.97M | 8.97% | 4,897,432 | 383.40K |
| 559 | VIVS | VivoSim Labs, Inc. | 4.88M | 2.19% | 17,657 | 142.00K |
| 560 | REVB | Revelation Biosciences, Inc. | 4.76M | -0.78% | 49,008 | - |
| 561 | MTVA | MetaVia Inc. | 4.62M | -7.10% | 245,835 | - |
| 562 | GNPX | Genprex, Inc. | 4.59M | 1.54% | 469,121 | - |
| 563 | BGMS | Bio Green Med Solution, Inc. | 4.58M | -1.58% | 12,143 | 81.00K |
| 564 | DCOY | Decoy Therapeutics Inc. | 4.58M | 13.59% | 46,399 | - |
| 565 | SILO | Silo Pharma, Inc. | 4.53M | 3.91% | 166,752 | 72.10K |
| 566 | INDP | Indaptus Therapeutics, Inc. | 4.19M | 1.08% | 33,308 | - |
| 567 | OGEN | Oragenics, Inc. | 4.10M | 6.70% | 278,563 | - |
| 568 | GLMD | Galmed Pharmaceuticals Ltd. | 4.05M | -6.79% | 18,245 | - |
| 569 | MTNB | Matinas BioPharma Holdings, Inc. | 3.87M | 0.45% | 6,511 | - |
| 570 | GRI | GRI Bio, Inc. | 3.61M | -2.53% | 31,146 | - |
| 571 | HCWB | HCW Biologics Inc. | 3.41M | -4.43% | 20,460 | 422.03K |
| 572 | AZTR | Azitra, Inc. | 3.29M | 12.53% | 5,785,386 | 7.50K |
| 573 | DRMA | Dermata Therapeutics, Inc. | 3.17M | 6.40% | 169,945 | - |
| 574 | SPRC | SciSparc Ltd. | 3.17M | 0.72% | 31,637 | 1.31M |
| 575 | XRTX | XORTX Therapeutics Inc. | 3.07M | -1.86% | 56,008 | - |
| 576 | CDT | CDT Equity Inc. | 3.03M | 2.21% | 26,502 | - |
| 577 | CLDI | Calidi Biotherapeutics, Inc. | 2.95M | 1.33% | 861,376 | - |
| 578 | ENVB | Enveric Biosciences, Inc. | 2.77M | 2.31% | 42,743 | - |
| 579 | PPCB | Propanc Biopharma, Inc. | 2.73M | 1.78% | 718,369 | - |
| 580 | SCNI | Scinai Immunotherapeutics Ltd. | 2.57M | -5.03% | 25,078 | 1.15M |
| 581 | ARTL | Artelo Biosciences, Inc. | 2.49M | 2.63% | 282,032 | - |
| 582 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.48M | -5.85% | 50,780 | 1.36M |
| 583 | ELAB | PMGC Holdings Inc. | 2.32M | -3.30% | 331,014 | 285.95K |
| 584 | LYRA | Lyra Therapeutics, Inc. | 2.31M | 1.72% | 9,260 | 600.00K |
| 585 | JAGX | Jaguar Health, Inc. | 2.23M | -16.85% | 1,278,517 | 11.79M |
| 586 | BBLG | Bone Biologics Corporation | 2.19M | -4.69% | 13,638 | - |
| 587 | ENSC | Ensysce Biosciences, Inc. | 1.95M | -1.66% | 390,157 | 4.49M |
| 588 | ADIL | Adial Pharmaceuticals, Inc. | 1.91M | -6.01% | 124,178 | - |
| 589 | CNSP | CNS Pharmaceuticals, Inc. | 1.87M | 2.72% | 25,134 | - |
| 590 | CMND | Clearmind Medicine Inc. | 1.83M | -10.53% | 106,151 | - |
| 591 | VRAX | Virax Biolabs Group Limited | 1.48M | -6.76% | 416,141 | 2.99K |
| 592 | ONCO | Onconetix, Inc. | 819.49K | 7.99% | 194,483 | 1.22M |
| 593 | BDRX | Biodexa Pharmaceuticals Plc | 796.85K | 4.86% | 50,056 | 104.90K |
| 594 | ADTX | Aditxt, Inc. | 770.35K | - | 269,763 | 5.95K |